BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
SIRT1
,
Angiogenesis
,
Obesity
,
Neuron
,
Metabolism of nitric oxide
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
papillomavirus human 16
Summary
General Info
Curated Studies
Most Correlated Studies
Primary skin fibroblasts overexpressing E6/E7 genes of HPV16, HPV18, HPV38b, HPV107 and HPV122
Dendritic cells and monocytes treated with different vaccines and TLR ligands
Gene expression signature of HPV in head and neck squamous cell carcinoma
Neonatal foreskin keratinocytes infected with E2 proteins of human papillomavirus 16 and 18
Oral keratinocytes overexpressing human papillomavirus type 16 (HPV16) E6 and E7 oncogenes
Explore Curated Studies Results
Literature
Most Relevant Literature
HPV16 E6 Gene Transcripts in Primary Type II Endometrial Carcinomas.
Association between Human Papillomavirus 16 Viral Load in Pregnancy and Preterm Birth.
Detection of high-risk HPV 16 genotypes in cervical cancers using isothermal DNA amplification with …
CRISPR-Cas12a-mediated dual-enzyme cascade amplification for sensitive colorimetric detection of HPV…
HCR/DNAzyme-triggered cascaded feedback cycle amplification for self-powered dual-photoelectrode det…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolesce…
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females
Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolesce…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ